Clinical Trial Update: Hypofractionated Imrt (Vmat-Ra) For Elderly Patients With Newly Diagnosed High Grade Glioma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hypofractionated IMRT delivered with VMAT-Ra for elderly patients with newly diagnosed high-grade glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Glioma | Phase 2 | Status: COMPLETED